All sponsors

Janssen Research & Development, LLC $JNJ

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS112
PHASE 3 / 2-375
RECRUITING46
READOUTS ≤12 MONTHS26
READOUT SLIPPED >6 MO40%

Delay Index: of 90 active trials registered more than a year ago, 36 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.8 months). See all sponsors →

Open Janssen Research & Development, LLC on the live radar map → 📅 $JNJ readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
GLOW
NCT03462719
P3Active, not recruitingLeukemia, Lymphocytic, Chronic, B-Cell2112021-02-26
QUEST
NCT03431350
P2Active, not recruitingProstatic Neoplasms, Castration-Resistant1362021-08-31 (+25 mo)
MAGNITUDE
NCT03748641
P3Active, not recruitingCastration-Resistant Prostatic Cancer7652021-10-08 (-9 mo)
MajesTEC-1
NCT04557098
P2Active, not recruitingHematological Malignancies1942021-11-09 (-3 mo)
Erdafitinib
NCT02365597
P2Active, not recruitingUrothelial Cancer2392022-09-15 (+79 mo)
Erdafitinib
NCT03473743
P1/2Active, not recruitingUrothelial Carcinoma1252022-09-30 (+35 mo)
PAPILLON
NCT04538664
P3Active, not recruitingCarcinoma, Non-Small-Cell Lung3082023-05-03 (+16 mo)
GRAVITI
NCT05197049
P3Active, not recruitingCrohn Disease3502023-07-04
MARIPOSA-2
NCT04988295
P3Active, not recruitingCarcinoma, Non-Small-Cell Lung7762023-07-10 (+1 mo)
PROTOSTAR
NCT03451851
P3Active, not recruitingPsoriasis1202023-07-19 (+6 mo)
MARIPOSA
NCT04487080
P3Active, not recruitingCarcinoma, Non-Small-Cell Lung10742023-08-11 (-9 mo)
QUASAR
NCT04033445
P2/3Active, not recruitingUlcerative Colitis10642023-09-19 (+15 mo)
GALAXI
NCT03466411
P2/3Active, not recruitingCrohn's Disease14092023-10-20 (+17 mo)
JNJ-63723283
NCT02908906
P1/2Active, not recruitingNeoplasms2342023-11-17 (+56 mo)
Nipocalimab
NCT04951622
P3RecruitingMyasthenia Gravis1992023-11-17
PURSUIT 2
NCT03596645
P3Active, not recruitingColitis, Ulcerative842023-11-21 (+23 mo)
PALOMA-3
NCT05388669
P3Active, not recruitingAdvanced or Metastatic Non-small Cell Lung Cancer4182024-01-03
Dexamethasone
NCT05663866
P2Active, not recruitingCarcinoma, Non-Small-Cell Lung682024-03-29 (-2 mo)
ASTRO
NCT05528510
P3Active, not recruitingColitis, Ulcerative4182024-04-02 (-1 mo)
THOR
NCT03390504
P3Active, not recruitingUrothelial Cancer6292024-04-15
CARTITUDE-4
NCT04181827
P3Active, not recruitingMultiple Myeloma4192024-05-01 (-23 mo)
ICONIC-TOTAL
NCT06095102
P3Active, not recruitingPlaque Psoriasis3112024-06-19 (-5 mo)
ICONIC-LEAD
NCT06095115
P3Active, not recruitingPlaque Psoriasis6842024-07-29 (-4 mo)
JNJ-77242113
NCT06143878
P3Active, not recruitingPlaque Psoriasis7742024-09-17 (-6 mo)
JNJ-77242113
NCT06220604
P3Active, not recruitingPlaque Psoriasis7312024-11-15 (-5 mo)
APEX
NCT04882098
P3Active, not recruitingArthritis, Psoriatic10542024-12-30 (+12 mo)
AMPLITUDE
NCT04497844
P3Active, not recruitingProstatic Neoplasms6962025-01-07 (+2 mo)
ENERGY
NCT04119050
P2/3Active, not recruitingWarm Autoimmune Hemolytic Anemia1182025-02-02 (+44 mo)
RedirecTT-1
NCT04586426
P1/2Active, not recruitingMultiple Myeloma2282025-03-18 (+41 mo)
DUET-UC
NCT05242484
P2Active, not recruitingColitis, Ulcerative5772025-05-15 (+9 mo)
DUET-CD
NCT05242471
P2Active, not recruitingCrohn's Disease7032025-05-23 (+9 mo)
SunRISe-1
NCT04640623
P2Active, not recruitingUrinary Bladder Neoplasms2202025-07-03 (+8 mo)
MajesTEC-3
NCT05083169
P3Active, not recruitingMultiple Myeloma5872025-08-01 (+6 mo)
MajesTEC-9
NCT05572515
P3Active, not recruitingMultiple Myeloma6142025-10-13 (+2 mo)
ICONIC-ASCEND
NCT06934226
P3Active, not recruitingPlaque Psoriasis7522025-11-17 (-24 mo)
AQUARIUS
NCT05250973
P2Active, not recruitingAmyloidosis1512026-02-04 (+14 mo)
MonumenTAL-6
NCT06208150
P3Active, not recruitingMultiple Myeloma8382026-04-01 (-14 mo)
ICONIC-PsA 1
NCT06878404
P3Active, not recruitingArthritis, Psoriatic5522026-05-25 (-4 mo)
LIBERTAS
NCT05884398
P3Active, not recruitingMetastatic Castrate-sensitive Prostate Cancer4202026-10-12 (-8 mo)
LIBREXIA-STROK
NCT05702034
P3Active, not recruitingIschemic Stroke; Ischemic Attack, Transient125232026-10-15
READY-AD
NCT07230860
P2Active, not recruitingDermatitis, Atopic1892026-11-19
PROTEUS
NCT03767244
P3Active, not recruitingProstatic Neoplasms25172026-12-01 (+31 mo)
LIBREXIA-AF
NCT05757869
P3Active, not recruitingAtrial Fibrillation202842026-12-08 (-3 mo)
Nipocalimab
NCT05327114
P2/3RecruitingPolyradiculoneuropathy, Chronic Inflammatory Demyelinating2012026-12-15 (+7 mo)
SunRISe-2
NCT04658862
P3Active, not recruitingUrinary Bladder Neoplasms5182026-12-30
Seltorexant
NCT06559306
P3RecruitingDepressive Disorder, Major7522026-12-30
CAN3001
NCT01804686
P3Active, not recruitingChronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma5392026-12-31
PolyDamas
NCT05908734
P1/2Active, not recruitingCarcinoma, Non-Small-Cell Lung712027-01-31 (+19 mo)
DAFFODIL
NCT06741969
P3Active, not recruitingSjogrens Syndrome6552027-02-04 (-11 mo)
QUASAR Jr
NCT06260163
P3Active, not recruitingColitis, Ulcerative1122027-02-10 (-15 mo)
ICONIC-PsA 2
NCT06807424
P3Active, not recruitingArthritis, Psoriatic8132027-02-10
CARTITUDE-2
NCT04133636
P2Active, not recruitingMultiple Myeloma2082027-02-26 (+59 mo)
OrigAMI-1
NCT05379595
P1/2RecruitingAdvanced or Metastatic Colorectal Cancer2252027-04-27 (+6 mo)
METalmark
NCT05488314
P1/2Active, not recruitingCarcinoma, Non-Small-Cell Lung572027-04-28 (+28 mo)
COCOON
NCT06120140
P2Active, not recruitingCarcinoma, Non-Small-Cell Lung3052027-05-31 (+26 mo)
TRIlogy-3
NCT07266441
P2Active, not recruitingMultiple Myeloma1682027-06-14
VELOTA
NCT07321873
P2Active, not recruitingArthritis, Psoriatic1572027-06-28
Nipocalimab
NCT05265273
P2/3RecruitingMyasthenia Gravis122027-06-30 (+27 mo)
MonumenTAL-1
NCT04634552
P2RecruitingHematological Malignancies5102027-06-30 (+45 mo)
MonumenTAL-3
NCT05455320
P3Active, not recruitingMultiple Myeloma8642027-07-30 (+18 mo)
AZALEA
NCT05912517
P3RecruitingHemolytic Disease of the Fetus and Newborn1202027-08-05
PALOMA-2
NCT05498428
P2RecruitingCarcinoma, Non-small-Cell Lung5202027-08-17 (+39 mo)
MonumenTAL-8
NCT06550895
P2Active, not recruitingMultiple Myeloma112027-08-26 (+10 mo)
EPIC
NCT07217587
P3RecruitingMyasthenia Gravis1152027-09-28
UNITED
NCT05092269
P3Active, not recruitingCrohn Disease; Colitis, Ulcerative1592027-09-29
MACARONI-23
NCT05923073
P3RecruitingCrohn's Disease1202027-10-27
KLK2-PASenger
NCT07225946
P3RecruitingProstatic Neoplasms, Castration-Resistant8002027-11-19
OrigAMI-3
NCT06750094
P3RecruitingColorectal Neoplasms7002027-12-15
FREESIA-3
NCT06533098
P3RecruitingThrombocytopenia, Neonatal Alloimmune502027-12-15
TAILOR
NCT05963074
P2Active, not recruitingLeukemia, Lymphocytic, Chronic, B-Cell; Small Lymphocytic Lymphoma3332027-12-15 (-9 mo)
TRI Pro
NCT07589634
P2RecruitingMultiple Myeloma2302027-12-31
ICONIC-UC
NCT07196748
P3Active, not recruitingColitis, Ulcerative8962028-01-14
JNJ-101556143
NCT07906717
P3RecruitingProstatic Neoplasms4002028-02-14
AmiNA
NCT07586202
P2RecruitingCarcinoma, Non-Small-Cell Lung682028-03-02
Erdafitinib Intravesical Delivery System
NCT05316155
P1/2Active, not recruitingNon-Muscle Invasive Bladder Neoplasms2352028-03-30 (+36 mo)
MoonRISe-3
NCT06919965
P3RecruitingNon-Muscle Invasive Bladder Neoplasms2202028-04-06 (+8 mo)
CARTITUDE-10
NCT07149857
P2RecruitingMultiple Myeloma602028-04-12 (+3 mo)
DUET ENCORE-CD
NCT07577843
P3RecruitingCrohn Disease4602028-06-12
MoonRISe-1
NCT06319820
P3RecruitingNon-Muscle Invasive Bladder Neoplasms6412028-06-28
DUET ENCORE-UC
NCT07577856
P3RecruitingColitis, Ulcerative6442028-08-11
JNJ-101556143 Formulation 1
NCT06800313
P1/2RecruitingMetastatic Prostate Cancer1902028-08-17 (+18 mo)
KLK2-comPAS
NCT07164443
P3RecruitingMetastatic Castration-resistant Prostatic Neoplasms12032028-08-18 (+3 mo)
Seltorexant
NCT07573176
P3RecruitingDepressive Disorder, Major6002028-08-24
ICONIC-CD
NCT07196722
P2/3RecruitingCrohn Disease10922028-09-19
CHARGE
NCT07499232
P3RecruitingCrohn Disease5302028-11-15
KaRAnaSa
NCT07227025
P1/2RecruitingCarcinoma, Non-Small-Cell Lung602028-11-30
GARDENIA-SLE
NCT07438496
P3RecruitingLupus Erythematosus, Systemic6002028-12-06
TRIlogy-4
NCT07258511
P3RecruitingMultiple Myeloma4002028-12-12
OrigAMI-2
NCT06662786
P3RecruitingColorectal Neoplasms10002028-12-15
Esketamine 56 mg
NCT07716098
P3RecruitingDepressive Disorder, Treatment-Resistant3482028-12-27
cAMeLot-1
NCT04811560
P1/2RecruitingAcute Leukemia4202028-12-29 (+60 mo)
Daratumumab
NCT05438043
P3Active, not recruitingMultiple Myeloma2142029-01-31 (+36 mo)
CARTITUDE-5
NCT04923893
P3Active, not recruitingMultiple Myeloma7432029-02-14 (+37 mo)
TRIlogy-5
NCT07518186
P3RecruitingMultiple Myeloma7002029-04-29
JNJ-101556143
NCT07832292
P2RecruitingProstatic Neoplasms1002029-05-17
COPERNICUS
NCT06667076
P2RecruitingCarcinoma, Non-Small-Cell Lung4802029-05-23
OrigAMI-5
NCT07276399
P3RecruitingSquamous Cell Carcinoma of Head and Neck6002029-06-18
cAMeLot-2
NCT06852222
P3RecruitingLeukemia, Myeloid, Acute6002029-06-22
JNJ-81201887
NCT06635148
P2/3RecruitingGeographic Atrophy; Macular Degeneration2742029-08-24
READY-BREATHE
NCT07746687
P2RecruitingAsthma4402029-09-11
SunRISe-3
NCT05714202
P3Active, not recruitingBladder Cancer11352029-09-18 (-8 mo)
FREESIA-1
NCT06449651
P3RecruitingThrombocytopenia, Neonatal Alloimmune392029-12-05
Talisman
NCT06500884
P2RecruitingMultiple Myeloma2102030-05-30 (+49 mo)
aMMbition
NCT06577025
P2Active, not recruitingMultiple Myeloma432030-09-02 (+1 mo)
TRIlogy-7
NCT07665450
P3RecruitingMultiple Myeloma10002030-09-04
SunRISe-5
NCT06211764
P3Active, not recruitingNon-Muscle Invasive Bladder Neoplasms2722030-11-27
AVENUE
NCT07227454
P3RecruitingDepressive Disorder, Major2582031-04-09
MajesTEC-7
NCT05552222
P3RecruitingMultiple Myeloma15902031-04-30 (+21 mo)
TRILOGY
NCT06663332
P3RecruitingCrohns Disease; Colitis, Ulcerative1962031-12-12
OrigAMI-4
NCT06385080
P1/2RecruitingSquamous Cell Carcinoma of Head and Neck2872032-12-27 (+77 mo)
TRIlogy-6
NCT07903272
P3Not yet recruitingMultiple Myeloma10002037-01-11
JNJ-90014496
NCT05421663
P1/2Active, not recruitingLymphoma, Non-Hodgkin; Lymphoma, B-Cell1662041-07-30